Clinical Trials Directory

Trials / Completed

CompletedNCT01159925

Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian Children

Epidemiologic Surveillance to Assess Trends in Acute Hepatitis A Among Children in Panama

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
1 Month – 15 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to collect epidemiological and clinical data to assess the vaccine impact and occurrence of confirmed acute hepatitis A cases in sentinel hospitals after the introduction of Havrix™ into the Expanded Program of Immunization.

Detailed description

This is an observational, prospective, multi-centre, sentinel based study in 3 hospitals in Panama. Hospitals are selected based on population density or hepatitis A disease burden. The Pan American Health Organization (PAHO) definition for a possible case of acute hepatitis A are used for subjects aged between \>1 month and \<15 years. Data regarding clinical and epidemiologic information are collected and serum samples are collected to test hepatitis A markers and determine if infection with hepatitis A virus has recently occurred. Surveillance will be for a period of approximately 2.5 years from the date of study initiation.

Conditions

Interventions

TypeNameDescription
PROCEDURESerum sampleSerum samples collected

Timeline

Start date
2009-07-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2010-07-12
Last updated
2012-11-22

Locations

1 site across 1 country: Panama

Source: ClinicalTrials.gov record NCT01159925. Inclusion in this directory is not an endorsement.